MedPath

A CLINICAL TRIAL O STUDY THE EFFECTIVENESS AND SAFETY OF FERRIC CARBOXYMALTOSE V/S IRON SUCROSE FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN POST NATAL WOME

Phase 2
Conditions
Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
Registration Number
CTRI/2023/04/052135
Lead Sponsor
Tezpur Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Post natal women with Hb >=7gm% to <11gm%

Exclusion Criteria

1. Post natal women with Hb < 7gm% and >11gm%

2. Patient not willing to give consent

3. Patient with known hypersensitivity to parenteral iron therapy

4. Patient with known liver disease, kidney disease, heart disease, HIV or thalassemia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath